Advances in genetics and genomics have transformed the understanding and treatment of cancer. This session focuses on hereditary and acquired genomic alterations, molecular profiling, epigenetic changes, and precision-oncology approaches that enable more individualized cancer prevention, diagnosis, prognosis, and treatment.
Abstract Scope and Participation
Topics may include cancer genetics, genomics, hereditary cancer syndromes, epigenetics, genomic profiling, molecular classification, pharmacogenomics, precision medicine, and biomarker-guided therapies. Researchers, geneticists, oncologists, molecular scientists, genetic counselors, and professionals involved in personalized cancer care are encouraged to contribute.







Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States